Sublingual Semaglutide: Dose, Benefits, and Side Effects

Discover how sublingual semaglutide is designed to work, why some patients may prefer it over injections, and how it compares to oral and injectable GLP-1s.

Key takeaways
  • Sublingual semaglutide is a compounded formulation intended as a needle-free alternative to GLP-1 injections or oral tablets. It is designed for absorption through the oral mucosa, which may support faster entry into the bloodstream compared to traditional swallowed tablets such as Rybelsus®; however, clinical comparisons are limited, and this formulation has not been reviewed or approved by the FDA.
  • Designed to bypass the digestive system, potentially supporting increased absorption and tolerability.
  • Reported side effects are generally similar to other GLP-1s and may be managed through dose titration and hydration.
  • Dosing is tailored to individual needs and adjusted under the guidance of a licensed healthcare provider.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

What Is Sublingual Semaglutide?

Sublingual semaglutide refers to a compounded GLP-1 receptor agonist formulation designed to dissolve under the tongue, allowing absorption through the oral mucosa. This route may bypass gastrointestinal breakdown and first-pass liver metabolism, which may allow for more direct absorption compared to oral tablets.

This formulation may be suitable for individuals seeking alternatives to injections or those who experience difficulty with oral tablets.

Learn more about Eden’s GLP-1 therapy offerings, available through licensed healthcare providers.

How Sublingual Semaglutide Works

Sublingual semaglutide is designed to be placed under the tongue, where it may be absorbed through the oral mucosa. Semaglutide, the active compound in this formulation, is believed to act similarly to other GLP-1 receptor agonists by:

  • Stimulating insulin secretion in response to meals
  • Reducing glucagon secretion
  • Slowing gastric emptying
  • Promoting satiety and reducing food intake

The mucoadhesive base used in some sublingual formulations is intended to prolong contact with the mucosal surface, which may help support absorption. However, there are currently no published clinical studies directly comparing the pharmacokinetics or outcomes of compounded sublingual semaglutide to FDA-approved oral or injectable formulations.

Potential Advantages of Sublingual Semaglutide

1. Needle-Free Administration

Sublingual semaglutide is administered without needles and may be a discreet option for individuals seeking alternatives to injections. Some formulations do not require refrigeration or injection-related training.

2. Ease of Use

Its ease of use may support consistent use, particularly for individuals who prefer non-injectable options. However, clinical adherence and outcome data for compounded sublingual semaglutide are limited.

3. Designed to Bypass the Digestive Tract

Sublingual delivery bypasses the digestive tract, which may influence how the drug is absorbed. However, data comparing fluctuations in drug levels or side effect profiles between sublingual and other delivery methods are currently lacking.

Comparing GLP-1 Administration Methods

Feature Injectable Oral Tablet Sublingual
Frequency Weekly for injectables (e.g., Ozempic®) Daily for Rybelsus® Daily for most compounded sublingual options
Bioavailability High ~0.8% Not established (compounded)
Onset Delayed Delayed Intended to act quickly; clinical data limited
GI Side Effects Varies; typical moderate Frequently reported Patient-reported as milder in some cases; not clinically validated
Convenience Requires injection supplies Take on empty stomach No needles; avoid food/drink before & after dosing
FDA Approval Yes (e.g., Ozempic®) Yes (Rybelsus®) No (compounded formulation; not FDA-reviewed)

Sublingual Semaglutide Dosing

Compounded sublingual semaglutide is available in a variety of strengths, such as 3 mg, and is dosed once daily under the tongue. A licensed healthcare provider will determine the starting dose and make adjustments based on your individual response and any side effects.

Because this formulation has not been reviewed or approved by the FDA, dosing practices are based on clinical judgment and patient-reported outcomes.

If you're interested in exploring this option, you can consult with a licensed healthcare provider through Eden to determine whether this therapy may be suitable for your health goals.

 Start your sublingual semaglutide consultation with licensed healthcare providers on the Eden platform.

Side Effects and How to Manage Them

While formal clinical trials have not evaluated the safety of compounded sublingual semaglutide, patients using this formulation have reported a range of potential side effects, including:

  • Nausea
  • Headache
  • Dry mouth
  • Taste changes
  • Mild irritation under the tongue

These effects are similar to those seen with other GLP-1 receptor agonists but may vary based on individual tolerance and route of administration.

To support tolerability, licensed healthcare providers may recommend the following general strategies:

  • Begin with a low dose and titrate slowly
  • Drink plenty of fluids
  • Avoid spicy or high-fat meals
  • Allow full dissolution under the tongue—do not chew or swallow early

Always follow the guidance of your licensed healthcare provider and report any persistent or concerning side effects promptly.

Storage and Administration Tips

  • Store sublingual tablets at room temperature, in a dry location away from direct sunlight or moisture, unless your compounding pharmacy provides different instructions.
  • Keep the tablets sealed in their original container to maintain integrity.
  • Consider taking the dose at the same time each day as part of your routine, unless otherwise directed.
  • Your licensed healthcare provider may recommend avoiding food or drink for a short period after administration to support mucosal absorption.

Always follow the specific storage and dosing instructions provided by your pharmacy and healthcare provider.

Final Thoughts

Compounded sublingual semaglutide provides a needle-free option for delivering semaglutide, a GLP-1 receptor agonist used in managing certain metabolic health goals. While this formulation has not been reviewed or approved by the FDA, it is available through licensed compounding pharmacies and prescribed under the supervision of a licensed healthcare provider.

Some patients prefer sublingual delivery due to its convenience or difficulty with injections. However, there are currently no clinical studies comparing the safety, absorption, or effectiveness of compounded sublingual semaglutide to FDA-approved injectable or oral GLP-1 formulations.

Learn more about Eden’s personalized GLP-1 therapy options

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or modifying any medication or treatment plan.

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

Frequently asked questions

Is sublingual semaglutide FDA-approved?

No. Semaglutide is FDA-approved in injectable (Ozempic®, Wegovy®) and oral (Rybelsus®) forms. However, sublingual semaglutide is a compounded formulation and has not been reviewed or approved by the FDA.

Who is sublingual semaglutide ideal for?

Sublingual semaglutide may be considered by individuals who prefer to avoid injections or who have difficulty tolerating oral tablets. A licensed healthcare provider can help determine whether this option is appropriate for your needs.

Does sublingual semaglutide work faster than tablets?

Sublingual administration is designed to bypass the digestive system, which may influence how quickly it is absorbed. However, there are no published clinical trials directly comparing the onset of action between compounded sublingual and oral tablet forms of semaglutide.

Are there any reported side effects specific to sublingual semaglutide?

Some individuals report mild irritation under the tongue or altered taste. Gastrointestinal symptoms such as nausea may still occur, though individual tolerance varies. Formal safety studies on the sublingual formulation have not been conducted.

Can I eat or drink after dosing?

Licensed healthcare providers may recommend waiting a few minutes after the tablet dissolves to support absorption through the oral mucosa. Follow the specific instructions provided with your prescription.

GLP-1 Treatments
Personalized doctor-led plans
As low as $196/mo*
Get started
Important safety information
Important safety information
Verified Customer
"I had an incredible experience, and the support that Eden provides is 10/10"
Kerstin
Verified Customer
“I had so many questions in the beginning, and both the doctor and customer support were so patient and thorough.”
Lane L.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

References